WuXi Biologics WKN: A2QJCN ISIN: KYG970081173 Forum: Aktien User: Summer.76

C Suisse: WUXI BIO (02269 HK) Shr Price Likely Bumpy on Vir COVID Neutrializing Antibody Clinical Trial Failure http://www.aastocks.com/en/stocks/analysis/stock-aafn-con/02269/NOW.1080338/hk-stock-news

Remote Pre-Approval Inspection Completed by EMA on WuXi Biologics' MFG4 Facility https://www.prnewswire.co.uk/news-releases/remote-pre-approval-inspection-completed-by-ema-on-wuxi-biologics-mfg4-facility-895797546.html

Eher allgemein und etwas länger. WuXi findet im unteren Drittel auch seine Erwähnung: China: Ein hoffnungsvoller Markt für Gesundheitsinnovationen https://e-fundresearch.com/newscenter/199-pgim-investments/artikel/40498-china-ein-hoffnungsvoller-markt-fuer-gesundheitsinnovationen

https://finance.sina.cn/hkstock/ggpj/2021-03-03/detail-ikftssaq0070680.d.html?from=wap Die Bank of Communications International veröffentlichte einen Bericht, wonach die neue Version des Krankenversicherungskatalogs ab dem 1. März vollständig implementiert sein wird. Es sind 119 neue Medikamente und 16 neu gelistete Medikamente enthalten. Die durchschnittliche Preissenkung für erfolgreich verhandelte Medikamente beträgt 50,64% . Die Aufnahme neu vermarkteter Arzneimittel in den Krankenversicherungskatalog setzt Signale für die Anerkennung und Unterstützung innovativer Arzneimittel und verbessert den Zugang der Patienten zu innovativen Arzneimitteln. Davon profitieren führende Pharmaunternehmen und CXO-Unternehmen, darunter China Biopharmaceuticals (01177-HK / Kauf) und WuXi Biologics (02269-HK / Kauf).

📍

DATE OF BOARD MEETING Download https://doc.irasia.com/listco/hk/wuxibiologics/announcement/a210226.pdf

WuXi Biologics (02269.HK) issued an announcement that the company would like to hold a board meeting on March 23, 2021 (Tuesday), in order to (including) consider and approve the group as of December 2020 Annual results and publication for the year ended on the 31st. https://m.jrj.com.cn/madapter/hk/2021/02/26163232033312.shtml

Hong Kong stocks slump with global sell-off as taper tantrum triggers bond market rout, mainland funds trim bets again https://amp.scmp.com/business/markets/article/3123202/hong-kong-stocks-plunge-global-sell-taper-tantrum-triggers-bond • Stocks crash across the region as traders begin to price in interest-rate increase amid policy tightening risks, inflation concerns • WuXi Biologics, Galaxy Entertainment and Meituan lead slump, mainland investors turn net sellers of Hong Kong stocks again Hong Kong stocks tumbled, joining a global rout, after a sell-off in US government bonds amid concerns central banks will unwind accommodative monetary policies that have fed an unprecedented rally in global equities. The Hang Seng Index sank 2.4 per cent to 29,342.49 at local noon break as 50 of the 52 members suffered losses. WuXi Biologics, Macau casino operator Galaxy Entertainment and Meituan retreated at least 5.8 per cent as the worst performers. ... WuXi Biologics fell 7.8 per cent to HK$96.20, the lowest since January 8. Galaxy dropped for a third day, losing 6.5 per cent to HK$69.25. Meituan 5.8 per cent to HK$349, the lowest since January 19. ...

WuXi Biologics Wins 2021 CMO Leadership Awards in All Six Core Categories https://www.prnewswire.com/news-releases/wuxi-biologics-wins-2021-cmo-leadership-awards-in-all-six-core-categories-301235088.html ...today announced that the company has been named a winner of the 2021 CMO Leadership Awards for a fourth year in a row. The company is proud to receive this distinction in all six award categories – capabilities, compatibility, expertise, quality, reliability, and service – and across the three respondent groups - Big Pharma, Small Pharma, and Overall (combined Big and Small Pharma).   ...

Allgemein zum Markt: Hong Kong stocks sink in biggest sell-off since May as city raises trading fees, mainland funds exit by record amounts https://sg.news.yahoo.com/hong-kong-stocks-sink-biggest-025724314.html Hong Kong stocks suffered the biggest sell-off in nine months amid rising volatility as traders dumped richly-valued popular bets, brushing aside optimistic economic outlook and dov ish comments from the Federal Reserve. A government plan to raise stock trading fees spooked investors. ...

WuXi Biologics (02269) sold 150,000 shares in a big lot, with a transaction price of $104.9 and an investment of 15.74 million http://www.aastocks.com/tc/stocks/news/aamm-news/AAT2102243697/1 [Large deal] WuXi Biologics (02269) sold a large deal at 10:25 in the morning, with a turnover of 150,000 and a transaction price of HK$104.9, involving an investment of 15.74 million.  So far, the stock price has fallen 1.959%. The highest price today is $109.4 and the lowest price is $104.6. The total trading volume is 871372 shares and the total trading value is HK$932.7 million.

BRIEF-JPMorgan Chase & Co's Long Position In WuXi Biologics Falls To 6.65% - HKEX Filing https://pub.webull.com/us/news-html/b3006a4930d044e5a4b1ae5300cc72e8.html?theme=2&_v=1&color=1&hl=en&sp=1&_v=1&theme=2&color=1&hl=en JPMORGAN CHASE & CO'S LONG POSITION IN WUXI BIOLOGICS 2269 HK DECREASED TO 6.65% ON FEB 17 FROM 9.04% - HKEX FILING https://di.hkex.com.hk/di/NSForm2.aspx?fn=CS20210222E00137&sa2=ns&sid=174136&sd=22/02/2020&ed=22/02/2021&sa1=cl&scsd=22/02/2020&sced=22/02/2021&sc=02269&src=Main&lang=EN&tk=ds

https://m.news.sina.com.tw/article/20210222/37683548.html WuXi Biologics (02269 HK) fell ...% after being previously reduced by US Capital Group’s 3.761 million shares, involving approximately HK$458 million in capital;...

BRIEF-JPMorgan Chase & Co's Long Position In Wuxi Biologics Increases To 10.03% - Filings https://pub.webull.com/us/news-html/249372f5fb37453da83a0f20cd4aee40.html?theme=2&_v=1&color=1&hl=en&sp=1&_v=1&theme=2&color=1&hl=en JPMORGAN CHASE & CO'S LONG POSITION IN WUXI BIOLOGICS 2269.HK INCREASED TO 10.03% BETWEEN FEB 8 AND FEB 9 FROM 6.71% - HKEX FILINGS ...

Ja das meinte ich ...nach den ganzen Impfrallyes hätte ich gerne wieder etwas stabileres :D Danke für den Hinweis...werde hier noch die Seitwärtsbewegung und ekne eventuelle Korrektur abwarten und einsteigen.

Meinst du die heißen Eisen, die potenzielle Raketen hervorbringen? WuXi ist eine CDMO und andere Unternehmen nutzen ihre Technologieplattform. Im Bericht vom 18.01. aus dem Kölner Stadtanzeiger (im Chat hinterlegt) findest du eine ganz gute Zusammenfassung zu ihr.